Concepedia

Publication | Open Access

Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes

DOIFull Paper Access

27

Citations

5

References

2018

Year

Philip Home, Karl-Michael Derwahl, M. Ziemen, Karin Wernicke‐Panten, Suzanne Pierre, Yvonne Kirchhein, Satish K. Garg
Diabetes Technology & Therapeutics

Abstract

Insulin lispro SAR342434 and the originator insulin lispro had a similar immunogenicity profile in people with T1DM or T2DM.

References

YearCitations

Page 1